Haideh Sabet, MD
Neurology · Alexandria, VANPI 1306857552
Payments from drug & device makers
Across 83 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$403
- AbbVie$300
- UCB, Inc.$153
- Supernus Pharmaceuticals, Inc.$124
- Sanofi$90
- Lundbeck LLC$90
- plus $601 from 17 others
What the payments were for
- Speaking & faculty fees$161%
- Food & beverage$1,74499%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 11 | $403 |
| AbbVie(2 entities) | 20 | $300 |
| UCB, Inc. | 6 | $153 |
| Supernus Pharmaceuticals, Inc. | 7 | $124 |
| Sanofi | 5 | $90 |
| Lundbeck LLC | 5 | $90 |
| EMD Serono, Inc. | 4 | $74 |
| Assertio Therapeutics, Inc. | 3 | $60 |
| GE HealthCare | 2 | $59 |
| Upsher-smith Laboratories LLC | 2 | $52 |
| Novartis | 2 | $46 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca | 1 | $23 |
| Biogen | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Aerie Pharmaceuticals, Inc. | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$238
How this compares
$1,760 in reported general payments places this provider in the 45th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 26 | $65,232 |
| Lamotrigine ErLamotrigine | 11 | $8,090 |
| Rivastigmine | 26 | $7,080 |
| AdlarityDonepezil Hcl | 12 | $6,519 |
| Duloxetine Hcl | 48 | $3,366 |
| Gabapentin | 119 | $2,279 |
| Memantine Hcl | 50 | $2,247 |
| Pregabalin | 23 | $1,501 |
| Lamotrigine | 45 | $1,302 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 55 | $930 |
| RivastigmineRivastigmine Tartrate | 23 | $885 |
| Levetiracetam ErLevetiracetam | 14 | $883 |
| Primidone | 23 | $838 |
| Galantamine Hbr | 12 | $831 |
| Donepezil Hcl | 51 | $509 |
Paid to pharmacies, not to this prescriber.
Other neurology in Alexandria
- Ramsey FalconerAlexandria$2.4M
- Simon FishmanAlexandria$1.6M
- John CochranAlexandria$79K
- Michelle BetzVirginia Beach$3.3M
- Daniel CohenNorfolk$2.9M
- Heidi CraytonVienna$2.5M
- Robert ShinCharlottesville$2.2M
- Ingrid Loma MillerNorfolk$1.2M
- Matthew BarrettHenrico$1.1M
- James BickselMc Lean$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.